Evidence map›Paper›PMID 32431924›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2020

Crystal structure and Hirshfeld surface analysis of hexyl 1-hexyl-2-oxo-1,2-di-hydro-quinoline-4-carboxyl-ate.

Younos Bouzian, Sevgi Kansiz, Lhassane Mahi, Noureddine Hamou Ahabchane, Joel T Mague, Necmi Dege, Khalid Karrouchi, El Mokhtar Essassi

Abstract read
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Younos BouzianLaboratory of Heterocyclic Organic Chemistry URAC 21, Pole of Competence Pharmacochemistry, Av Ibn Battouta, BP 1014, Faculty of Sciences, Mohammed V University, Rabat, Morocco.
Sevgi KansizDepartment of Fundamental Sciences, Faculty of Engineering, Samsun University, Samsun 55420, Turkey.
Lhassane MahiMoroccan Foundation for Advanced Science Innovation and Research (Mascir), Department of Nanotechnology, Rabat Design Center, Rue Mohamed Al Jazouli-Madinat Al Irfane, Rabat 10 100, Morocco.
Noureddine Hamou AhabchaneLaboratory of Heterocyclic Organic Chemistry URAC 21, Pole of Competence Pharmacochemistry, Av Ibn Battouta, BP 1014, Faculty of Sciences, Mohammed V University, Rabat, Morocco.
Joel T MagueDepartment of Chemistry, Tulane University, New Orleans, LA 70118, USA.ORCID https://orcid.org/0000-0003-3488-1945
Necmi DegeDepartment of Physics, Faculty of Arts and Sciences, Ondokuz Mayıs University, Samsun, 55200, Turkey.ORCID https://orcid.org/0000-0003-0660-4721
Khalid KarrouchiLaboratory of Analytical Chemistry and Bromatology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco.ORCID https://orcid.org/0000-0002-8075-8051
El Mokhtar EssassiLaboratory of Heterocyclic Organic Chemistry URAC 21, Pole of Competence Pharmacochemistry, Av Ibn Battouta, BP 1014, Faculty of Sciences, Mohammed V University, Rabat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The asymmetric unit of the title compound, C

Indexed as

aliphatic chainscrystal structuredi­hydro­quinolineHirshfeld surface analysisπ-stacking

Identifiers

PMID32431924
PMCPMC7199246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.